Skip to main content
ADVANCED SEARCH
Log in
Top
Current Obesity Reports
Published in:

06-05-2024 | Obesity | REVIEW

Beyond Obesity and Overweight: the Clinical Assessment and Treatment of Excess Body Fat In Children

Part 2 — the Prescription of Low-Carbohydrate Eating as the First Approach

Authors: Mark Cucuzzella, James Bailes, Jenny Favret, Nina Paddu, Anna Beth Bradley

Published in: Current Obesity Reports | Issue 2/2024

Login to get access

Abstract

Purpose of Review

Pediatric obesity and comorbidities related to insulin resistance continue to be a growing public health crisis. If lifestyle measures are unsuccessful, pharmacological and surgical interventions are offered. In this paper, we describe the driving force of the obesity crisis: hyperinsulinemia and the development of insulin resistance. We give historical background of key policy issues which have contributed to this pandemic as well as the physiologic mechanisms of insulin resistance. The prevalence of obesity will continue to rise unless the root cause of hyperinsulinemia is addressed.

Recent Findings

Current research on insulin resistance demonstrates that a decreased consumption of carbohydrates is an effective first-line dietary intervention for the treatment of obesity and related metabolic diseases. Evidence shows it is safe and beneficial.

Summary

A low-carbohydrate eating pattern can be helpful to address pediatric obesity. However, there must be policy guardrails in place to ensure that this is a sustainable and viable option for children and their families. There must be a change in the nutritional environment to help individuals battle the chronic disease of obesity.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Beyond Obesity and Overweight: the Clinical Assessment and Treatment of Excess Body Fat In Children
Part 2 — the Prescription of Low-Carbohydrate Eating as the First Approach
Authors
Mark Cucuzzella
James Bailes
Jenny Favret
Nina Paddu
Anna Beth Bradley
Publication date
06-05-2024
Publisher
Springer US
Published in
Current Obesity Reports / Issue 2/2024
Electronic ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-024-00564-1

Other articles of this Issue 2/2024

Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease

Adjuvant and Neo-Adjuvant Anti-Obesity Medications and Bariatric Surgery: A Scoping Review

Behavioral Lifestyle Interventions for Weight Loss in Overweight or Obese Patients with Type 2 Diabetes: A Systematic Review of the Literature

Correction: Effects of Calorie Restriction on Preserving Male Fertility Particularly in a State of Obesity

Weight Gain in Midlife Women

Ultra-Processed Food Addiction: A Research Update

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar
Image Credits